Stephen Thomas
Direttore/Membro del Consiglio presso ELIEM THERAPEUTICS, INC.
Patrimonio netto: 738 779 $ in data 30/06/2024
Profilo
Stephen Thomas was the founder of Ichorion Therapeutics, Inc. (founded in 2017) where he held the title of Chief Scientific Officer from 2017 to 2018.
He was also the founder of Tenet Medicines, Inc. (founded in 2023) where he served as the Chief Executive Officer from 2023 to 2024.
Currently, Dr. Thomas is the Director at Eliem Therapeutics, Inc. since 2024.
Previously, he worked as the Chief Scientific Officer at ValenzaBio, Inc. from 2020 to 2023.
Dr. Thomas obtained a doctorate degree from The Trustees of Columbia University in The City of New York.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ELIEM THERAPEUTICS, INC.
0.16% | 27/06/2024 | 103 907 ( 0.16% ) | 738 779 $ | 30/06/2024 |
Posizioni attive di Stephen Thomas
| Società | Posizione | Inizio |
|---|---|---|
| ELIEM THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 27/06/2024 |
Precedenti posizioni note di Stephen Thomas
| Società | Posizione | Fine |
|---|---|---|
ValenzaBio, Inc.
 ValenzaBio, Inc. BiotechnologyHealth Technology ValenzaBio, Inc. develops safe and effective treatment options for patients with autoimmune and inflammatory diseases. The company is headquartered in Bethesda, MD. | Direttore Tecnico/Scientifico/R&S | 01/01/2023 |
Ichorion Therapeutics, Inc.
 Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ichorion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of treatments for rare diseases. It focuses on a pipeline of genetically-targeted therapies for inherited metabolic disorders known as Inborn Errors of Metabolism. The company was founded by Stephen Thomas on July 7, 2017 and is headquartered in New York, NY. | Fondatore | 01/09/2018 |
Formazione di Stephen Thomas
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ELIEM THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Ichorion Therapeutics, Inc.
Ichorion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ichorion Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of treatments for rare diseases. It focuses on a pipeline of genetically-targeted therapies for inherited metabolic disorders known as Inborn Errors of Metabolism. The company was founded by Stephen Thomas on July 7, 2017 and is headquartered in New York, NY. | Health Technology |
ValenzaBio, Inc.
ValenzaBio, Inc. BiotechnologyHealth Technology ValenzaBio, Inc. develops safe and effective treatment options for patients with autoimmune and inflammatory diseases. The company is headquartered in Bethesda, MD. | Health Technology |
- Borsa valori
- Insiders
- Stephen Thomas
